|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Atherosclerosis | |||||
| Ischemia | |||||
| Myocardial Infarction | |||||
| Cerebrovascular Accident | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cerebral Infarction | |||||
| Infarction | |||||
| Stroke | |||||
| 3 | More general conditions related to this trial | ||||
| Arterial Occlusive Diseases | |||||
| Arteriosclerosis | |||||
| Brain Diseases | |||||
| Brain Infarction | |||||
| Brain Ischemia | |||||
| Cardiovascular Diseases | |||||
| Central Nervous System Diseases | |||||
| Cerebrovascular Disorders | |||||
| Heart Diseases | |||||
| Myocardial Ischemia | |||||
| Necrosis | |||||
| Nervous System Diseases | |||||
| Pathologic Processes | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| SCH 530348 | |||||
| Placebo | |||||
| 5 | Sponsors listed in this trial | ||||
| Schering-Plough | |||||
| The TIMI Study Group | |||||
| Duke University | |||||